Abstract
Brain functional networks (BFNs) constructed via manifold regularization (MR) have emerged as a powerful tool in finding new biomarkers for brain disease diagnosis. However, they only describe the pair-wise relationship between two brain regions, and cannot describe the functional interaction between multiple brain regions, or the high-order relationship, well. To solve this issue, we propose a method to construct dynamic BFNs (DBFNs) via hyper-graph MR (HMR) and employ it to classify mild cognitive impairment (MCI) subjects. First, we construct DBFNs via Pearson’s correlation (PC) method and remodel the PC method as an optimization model. Then, we use k-nearest neighbor (KNN) algorithm to construct the hyper-graph and obtain the hyper-graph manifold regularizer based on the hyper-graph. We introduce the hyper-graph manifold regularizer and the L1-norm regularizer into the PC-based optimization model to optimize DBFNs and obtain the final sparse DBFNs (SDBFNs). Finally, we conduct classification experiments to classify MCI subjects from normal subjects to verify the effectiveness of our method. Experimental results show that the proposed method achieves better classification performance compared with other state-of-the-art methods, and the classification accuracy (ACC), the sensitivity (SEN), the specificity (SPE), and the area under the curve (AUC) reach 82.4946 ± 0.2827%, 77.2473 ± 0.5747%, 87.7419 ± 0.2286%, and 0.9021 ± 0.0007, respectively. This method expands the MR method and DBFNs with more biological significance. It can effectively improve the classification performance of DBFNs for MCI, and has certain reference value for the research and auxiliary diagnosis of Alzheimer’s disease (AD).
Highlights
Alzheimer’s disease (AD) is a primary degenerative brain disease that occurs in senectitude and presenium (Lu et al, 2019; Bi et al, 2021)
We propose a method for constructing dynamic brain functional network (BFN) (DBFNs) via hyper-graph manifold regularization (MR) (HMR) and apply this method to differentiate mild cognitive impairment (MCI) subjects from normal subjects
Inspired by the research of Li et al (2017), we propose a method for constructing DBFNs based on HMR, and add the
Summary
Alzheimer’s disease (AD) is a primary degenerative brain disease that occurs in senectitude and presenium (Lu et al, 2019; Bi et al, 2021). MCI is mostly manifested as a decline in cognitive function and memory, but it does not affect the daily life of patients (Muldoon and Bassett, 2016). Related research has shown that the annual conversion rate of MCI to AD is about 10–15% (Jiao et al, 2014; Zhang et al, 2015b). Active intervention treatment for MCI can improve or delay its cognitive decline and even the development of AD (Alzheimer’s Association, 2012). The accurate identification of MCI and the intervention of MCI through drug and non-drug pathways to reduce the AD conversion rate have attracted great attention from researchers (Gauthier et al, 2006; Tobia et al, 2017). It is important to explore which subjects will progress from MCI to AD, as there are predictors of progression that will indicate a more rapid rate of progression in MCI subjects
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.